Results 131 to 140 of about 91,755 (270)
Based on a 3D‐quantitative structure‐activity relationship pharmacophore model, structural optimization of Y6 yielded Y7f. Mechanistic studies revealed that Y7f acted as a programmed death receptor 1/programmed cell death ligand 1 (PD‐L1) interaction inhibitor by inducing PD‐L1 dimerization. Y7f restored T‐cell function.
Menglin Yu +15 more
wiley +1 more source
An exposure–response (E–R) safety analysis was conducted across adult and pediatric (
Shengnan Du +7 more
doaj +1 more source
The CD47–SIRPα axis has emerged as a critical innate immune checkpoint that suppresses macrophage‐mediated phagocytosis through a canonical “don't eat me” signal and enables tumor immune evasion. We comprehensively summarize the structural and biological features of CD47 and the molecular mechanisms underlying CD47‐mediated regulation of phagocytosis ...
Ruimei Zhou +4 more
wiley +1 more source
Primary renal angiosarcoma: A case series and literature review
Abstract Background Primary renal angiosarcoma (PRA) is an exceedingly rare and aggressive malignant vascular neoplasm of the kidney. Its imaging appearance overlaps with more common renal malignancies, making preoperative diagnosis challenging. We present four cases of histologically confirmed PRA and describe their clinical, imaging, pathologic, and ...
Ann Shi, Min Dai, Erin Zheng, James Jing
wiley +1 more source
ABSTRACT With the approval of immunotherapies by regulatory bodies, head and neck squamous cell carcinoma (HNSCC) treatment has been revolutionized, and anti‐programmed cell death‐1 (anti‐PD‐1) agents are now the standard for platinum‐resistant recurrent/metastatic HNSCC.
Xiao‐Tong Yan +2 more
wiley +1 more source
ABSTRACT Hypopharyngeal squamous cell carcinoma (HSCC) is an aggressive subtype of head and neck squamous cell carcinoma with insidious onset, early metastasis, and dismal prognosis. Conventional multimodal therapy achieves limited survival benefit, highlighting an urgent need for refined precision strategies.
Ce Li +12 more
wiley +1 more source
Nivolumab resistance in head and neck squamous cell carcinoma patients and future perspectives
Head and neck cancer (HNC) cases are increasing globally, with resistance to immunotherapies such as nivolumab posing a significant challenge. This systematic review examines the mechanisms of nivolumab resistance in HNC, with a focus on intrinsic tumor ...
Anna Mydlak +4 more
core +1 more source
ABSTRACT Extramammary Paget's disease (EMPD) is a rare cutaneous malignancy for which evidence regarding stage‐specific prognosis and treatment outcomes remains limited. We retrospectively analyzed 104 patients with EMPD treated at a single Japanese institution between November 2012 and December 2025.
Manami Takahashi‐Watanabe +7 more
wiley +1 more source
Expanding on the growing evidence for neoadjuvant immunotherapy in resectable non‐small cell lung cancer, this study explored neoadjuvant nivolumab ± denosumab. Two of the 10 treated patients achieved a pathological complete response. CD8 T‐cell infiltration correlated with pathological response, warranting ongoing translational research to understand ...
Elizabeth Ahern +11 more
wiley +1 more source

